Europe (WHO region) vs Tonga: New cases tested for RR-/MDR-TB
Europe (WHO region)
88.0%
in 2024
Tonga
100.0%
in 2023
Europe (WHO region) rank
3rd
Tonga rank
1st
New cases tested for RR-/MDR-TB over time
- Europe (WHO region)
- Tonga
How they compare
Tonga currently reports 100.0% against 88.0% in Europe (WHO region), a difference of 12.0%.
That makes Tonga's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Tonga ranks 1st of 11 groups.
Across the 2 decades both report, Europe (WHO region) averaged higher in 1 and Tonga in 1.
Head to head by decade
| Decade | Europe (WHO region) | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.6% | 30.0% | 54.6% | Europe (WHO region) |
| 2020s | 91.5% | 100.0% | 8.5% | Tonga |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Europe (WHO region) or Tonga?
- Tonga, at 100.0% against 88.0% in Europe (WHO region) as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Europe (WHO region) and Tonga?
- 12.0%, with Tonga ahead.
- How many years of comparable data are there for Europe (WHO region) and Tonga?
- 14 years are reported by both, from 2010 to 2023.
- How do Europe (WHO region) and Tonga rank globally for new cases tested for rr-/mdr-tb?
- Europe (WHO region) ranks 3rd and Tonga ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.